AMRN Q4 2020 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$167M+16.7% YoY

Gross Profit

$132M79.2% margin

Operating Income

$7M4.3% margin

Net Income

$5M2.9% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

+6.9%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$966M

Total Liabilities

$339M

Stockholders' Equity

$628M

Cash & Equivalents

$187M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$167M	$143M	+16.7%
Gross Profit	$132M	$113M	+17.6%
Operating Income	$7M	$5M	+30.4%
Net Income	$5M	$7M	-30.3%

Revenue Segments

Product

$166M99%

Licensing And Royalty

$1M1%